Resource Library
Press Release
Sapient’s Diagnostic Collaboration with Bay Area Lyme Foundation Featured in the Foundation’s Annual Impact Update Report
San Diego, CA—Sapient, a full-service bioanalytical organization transforming drug development through biomarker discovery, has been featured in the Bay Area…
Webinar
Smaller, Faster & More Effective: Clinical Trial Enrichment Using Circulating Biomarkers
March 8, 2022 | 12:30pm ET / 9:30am PT | Hosted by AAPS…
Brochure
Sapient Fact Sheet
At Sapient, we believe that drugs can be developed much faster, cheaper and more effectively through biomarker-driven drug discovery. Biomarkers…
Video
Platform Explainer: How Sapient Accelerates Biomarker Discovery
At Sapient, we believe biomarker-driven drug development can transform lives – and accelerate the process at a fraction of…
Article
Biomarker-Driven Clinical Trials: Enriched with Biology, Evolved for a New Era
Why are large, expensive clinical trials so common? It stems from the challenge of needing to demonstrate treatment efficacy in…
Press Release
Philip Worboys, Ph.D. Joins Sapient as Head of Translational Science
San Diego, CA—Sapient, a full-service bioanalytical research organization transforming the efficiency of biomarker discovery for pharmaceutical and biotechnology sponsors, announced…
Webinar
Large-Scale Mass Spectrometry Profiling: Accelerated Biomarker Discovery to Drive Drug Development
Now On Demand | Hosted by AAPS WATCH…
Article
Getting Drug Development Right
The omics revolution has enabled many breakthroughs in our understanding of disease biology, but the productivity of clinical drug development…
Brochure
Circulating Biomarker Discovery at Unprecedented Speed & Scale
Did you know that underlying risks for most common human diseases are not encoded in DNA sequence? Rather, they are…
Paper
Deep Neural Networks for Classification of LC-MS Spectral Peaks
Nontargeted LC-MS can assay thousands of chemical entities in a single biospecimen, but in that crush of data, how do…